Genetype - Unlocking personalised preventative health
Genetic Technologies (ASX: GTG, NASDAQ Global Market: GENE) is a leader in the development and commercialisation of genetic risk assessment technology.
Significant progress has been made in understanding the role of hereditary risk in chronic disease, however, many chronic conditions cannot be predicted by this risk alone.
We’re transforming the conversation. Transitioning from a one-size-fits-all model to personalised, predictive health assessment – where each person has the information, they need to manage their health according to their own risk.
Backed by over 20 years of experience, our doctors, scientist and technicians are translating genetic information into multi-tests that uniquely combine genetic and clinical risk models to predict risk of chronic diseases before onset.
We’re empowering physicians to improve health outcomes for people around the world. Tracking disease to its source. Enabling a new era of personalised medicine.
Company Details
- Employees
- 25
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- gtglabs.com
- Keywords
- Biotechnology.
Genetype Questions
Genetype's website is gtglabs.com
Genetype's LinkedIn profile is https://au.linkedin.com/company/genetype-limited
Genetype has
25 employees.
View email and phone details for 25
employees at Genetype.
Genetype's industry is
Biotechnology Research
Genetype's categories are Biotechnology Research
Genetype's founding year is 1989
